期刊文献+

ICU患者假丝酵母菌菌血症的预后危险因素分析 被引量:4

Risk factors for prognosis of ICU patients with candidemia
原文传递
导出
摘要 目的分析重症监护病房(ICU)假丝酵母菌菌血症患者的临床和微生物特征,评价其死亡的预后危险因素,以指导临床治疗。方法回顾性分析2005年6月-2013年5月医院ICU 69例假丝酵母菌菌血症患者的临床资料,分析病原菌种类、基础疾病、危险因素、预后情况,使用单因素分析及多因素logistic回归分析假丝酵母菌菌血症死亡的相关危险因素;使用SPSS13.0软件对数据进行统计分析。结果血培养共分离到69株假丝酵母菌属,其中白色假丝酵母菌35株占50.7%,光滑假丝酵母菌12株占17.4%,近平滑假丝酵母菌6株占8.7%,热带假丝酵母菌5株占7.2%,经单因素分析及多因素logistic回归分析发现,并发感染性休克(OR=8.601,95%CI为1.756-42.120)、合并细菌菌血症(OR=32.393,95%CI为3.686-284.657)、低蛋白血症(OR=25.496,95%CI为2.876-226.067)为死亡的独立危险因素。结论 ICU假丝酵母菌菌血症以白色假丝酵母菌为主,病死率高,应针对危险因素采取相应治疗措施。 OBJECTIVE To observe the clinical and microbiological characteristics of the patients with candidemia in the intensive care unit(ICU)and evaluate the risk factors for the prognosis of death so as to provide guidance for clinical treatment.METHODS The clinical data of 69 patients with candidemia who were treated in the ICU from Jun 2005 to May 2013 were retrospectively analyzed;the distribution of pathogens,underlying diseases,risk factors,and prognosis were observed.The univariate analysis and multivariate logistic regression analysis were carried out to investigate the related risk factors for the death of the patients with candidemia,and the statistical analysis of data was performed with the use of SPSS13.0software.RESULTS A total of 69 strains of Candida were isolated through blood culture,including 35(50.7%)strains of Candida albicans,12(17.4%)strains of Candida glabrata,6(8.7%)strains of Candida parapsilosis,and 5(7.2%)strains of Candida tropicalis.The univariate analysis and multivariate logistic regression analysis indicated that the independent risk factors for the death included the complication of septic shock(OR=8.601,95%CI1.756~42.120),complication of bacteremia(OR=32.393,95%CI 3.686~284.657),and hypoalbuminemia(OR =25.496,95%CI 2.876~226.067).CONCLUSIONThe C.albicans is dominant among the Candidastrains isolated from the ICU patients with candidemia,and the mortality rate is high.It is necessary to take corresponding treatment measures aiming at the risk factors.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2016年第1期28-30,共3页 Chinese Journal of Nosocomiology
基金 浙江省自然科学基金资助项目(LY13H190008)
关键词 重症监护病房 假丝酵母菌菌血症 危险因素 预后 Intensive care unit Candidemia Risk factor Prognosis
  • 相关文献

参考文献8

  • 1Lortholary O,Renaudat C,Sitbon K,et al.Worrisome trends in incidence and mortality of candidemia in intensive care units(Paris area,2002-2010)[J].Intensive Care Med,2014,40(9):1303-1312.
  • 2Yang ZT,Wu L,Liu XY,et al.Epidemiology,species distribution and outcome of nosocomial Candida spp.bloodstream infection in Shanghai[J].BMC Infect Dis,2014(14):241.
  • 3殷琪琦,章云涛,方强.75例重症监护病房假丝酵母菌血症的死亡危险性分析[J].中华医院感染学杂志,2008,18(5):740-743. 被引量:6
  • 4Morrell M,Fraser VJ,Kollef MH.Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained:apotential risk factor for hospital mortality[J].Antimicrob Agents Chemother,2005,49(9):3640-3645.
  • 5Ha YE,Peck KR,Joo EJ,et al.Impact of first-line antifungal agents on the outcomes and costs of candidemia[J].Antimicrob Agents Chemother,2012,56(7):3950-3956.
  • 6Kludze-Forson M,Eschenauer GA,Kubin CJ,et al.The impact of delaying the initiation of appropriate antifungal treatment for Candida bloodstream infection[J].Med Mycol,2010,48(2):436-439.
  • 7Hadley S,Lee WW,Ruthazer R,et al.Candidemiaas a cause of septic shock and multiple organ failure in nonimmunocompromised patients[J].Crit Care Med,2002,30(8):1808-1814.
  • 8Guery BP,Arendrup MC,Auzinger G,et al.Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients:Part I.epidemiology and diagnosis[J].Intensive Care Med,2009,35(1):55-62.

二级参考文献7

  • 1Eggimann P,Calandra T,Fluckiger U,et al.Invasive candidiasis:comparison of management choices by infectious disease and critical specialists[J].Intensive Care Med,2005,31(11):1514-1521.
  • 2Falagas ME,Apostolou KE,Pappas VD.Attributable mor tality of candidemia:a systematic review of matched cohort and case-control studies[J].Eur J Clin Microbiol Infect Dis,2006,25(7):419-425.
  • 3Castagnola E,Marazzi MG,Tacchella A.et a1.Broviac catheter-related candidemia[J].Pediatr Infect Dis J,2005,24(8):747-749.
  • 4Pappas PG,Rex JH,Lee J,et al.A prospective observational study of candidemia:epidemiology,therapy,and influences on mortality in hospitalized adult and pediatric patients[J].Clin Infect Dis,2003,37(5):634-643.
  • 5Ellis M,Hedstrom U,Jumaa P,et al.Epidemiology,presentation,management and outcome of candidemia in a tertiary care teaching hospital in the United Arab Emirates,1995-2001[J].Med Mycol,2003,41(6):521-528.
  • 6Akbar DH,Tahawi AT.Candidemia at a university hospital:epidemiology,risk factors and predictors of mortality[J].Ann Saudi Med,2001,21(3-4):178-182.
  • 7赵心懋,徐英春,杨雪松,马洋,谢秀丽,陈民钧.59例假丝酵母菌属菌血症的危险因素与预后分析[J].中华医院感染学杂志,2007,17(9):1169-1170. 被引量:12

共引文献5

同被引文献41

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部